INTRODUCTION
There are approximately 165 species of Chromolaena distributed in the tropical and warm temperate regions (Mabberley, 1997) . Chromolaena odorata (Asteraceae) (L.) R.M. King & H. Rob. (syn.Eupatorium odoratum L.), originally ranged from Southern Mexico to Argentina and the Caribbean (Morto, 1987) , but has been introduced into the old World tropics where it has become an invasive species (Zachariades et al., 2009) . The plant has exhibited allelopathic effects and has been reported to cause livestock death (Zachariades et al., 2009) . Medicinally, the plant decoction is taken as a remedy for coughs and cold or in bath to treat skin diseases (Morto, 1987) . The plant is used in West African traditional medicine as a wound healing and a local antiseptic agent (Adjanohoun et al., 1979; Inya-Agha et al., 1987) . The chemical composition, insecticidal (Bouda et al., 2009) , insect repellent (Cui et al., 2009 ), antimicrobial, fungicidal (Inya-Agha et al., 1987 Bamba et al., 1993) and acaricide activities of C. odorata essential oil have been studied by (Iwu et al., 1984; Bamba et al., 1993; Chowdhury, 2002; Ling et al., 200; Inya-Agha et al., 1987; Cui et al., 2009; Pisutthanan et al., 2006; Owolabi et al., 2010; Tedonkeng et al., 2004; Cosme Kossouoh et al., 2011; Avlessi Felicien et al., 2012) .
Kurane-type diterpenoids were isolated (Pascal Wafo et al., 2011) . The present work is to isolate and characterize the compound (I) by IR, 1 H-NMR, 13 C-NMR and MS spectra. Further, the compound (I) was carried for in-vitro cytotoxicity against HepG2, cancer cell lines.
MATERIAL AND METHODS

Plant material
Fresh leaves of C. odorata was collected in October, 2009, from Palakkad district, Kerala and the plant species was authenticated in the Department of life science, Karpagam University, Coimbatore-21. Voucher specimen was preserved in the same Department (No. KU11CHE1913).
Isolation of the essential oil
500g of fresh leaves of C .odorata was hydro distilled for 4 h in a modified Clevenger-type apparatus to yield 0.2 % of essential oil. The essential oil so obtained was stored in a sealed glass bottle with screw lid cover under refrigeration at 4°C.
Isolation of the compound (I)
In an attempt to isolate components of the essential oil, it was subjected to column chromatography. It was eluted with the solvent petroleum ether followed by a mixture of petroleum ether: ethylacetate. Fractions of 30 ml were collected and monitored by TLC. Fractions 2 to 4 were homogenous by tlc and on concentration after mixing yielded a residue of 80.10 mg.
General
1 H-NMR and 13 C-NMR spectra were recorded on a
Bruker AM-400 (400 MHz) instrument; chemical shifts δ in ppm with TMS as internal standard, coupling constants J in Hz. Electrospray Ionization-MS data were recorded on a Bruker Esquire 3000+ Ion-trap mass spectrometer and Electron Impact-MS was performed on a Finnigan MAT-95 mass spectrometer.
Perkin -E/model 1650 IR instrument was used to carried the IR spectra.
Compound (I)
IR ν max (KBr) cm -1 ; 1600, 3400, 1285. 1 H-NMR and Spectra 13 C-NMR were shown in Table. 1and 2. 
MTT assay for Cytotoxicity screening
The Hepatocellular carcinoma cells (HepG2), were obtained from National Centre for Cell Science (NCCS), Pune. The HepG2 cells were grown in Eagles Minimum Essential Medium (EMEM) containing 10% fetal bovine serum (FBS).
For screening experiment, the cells were seeded into 96-well plates in 100µl of respective medium containing 10% FBS, at plating density of 10,000 cells/well and incubated at 37 0 C, 5% CO 2 , 95% air and 100% relative humidity for 24 h prior to addition of essential oil. The essential oil was solubilized in dimethylsulfoxide and diluted in respective medium containing 1% FBS. After 24 h, the medium was replaced with respective medium with 1% FBS containing the oil at various concentration ( 12.5, 25, 50, 100, 200, 300 µg/ml etc… ) and incubated at 37 0 C, 5% CO 2 , 95% air and 100% relative humidity for 48h. Triplicate was maintained and the medium containing without oil served as control. After 48h, 10µl of MTT (5mg/ml) in phosphate buffered saline (PBS) was added to each well and incubated at 37°C for 4h. The medium with MTT was then flicked off and the formed formazan crystals were solubilized in 100 µl of DMSO and then measured the absorbance at 570 nm using micro plate reader.
Determination of IC 50
% cell inhibition was determined using the following formula and graph was plotted between % Cell inhibition and concentration and from this IC 50 was calculated.
% Cell Inhibition = 100 -Abs (drug)/Abs (control) x100.
RESULTS AND DISCUSSION
The compound I isolated as a colourless gum the C.odorata was identified as a derivative of 19-hydroxy amyrin analysed for C 43 H 68 O evidenced by the EI-MS by showing a molecular ion peak, [M] + at 600.3145 and a base peak at m/z 234 indicating of amyrin type of compound. The IR spectra showed strong absorption at 3400 cm -1 for hydroxyl group1600 and 1285 cm -1 indicating the presence of C=C and another moity C-O in the molecule. We employed MTT assay, a simple and reliable technique, which measures cell viability for screening the anticancer activity and the results are shown in table 3.
The viability of cancer cells after incubation with different concentrations of compound (I) are depicted in Fig.2  (HepG2 cancer cell line) . The incubation with different concentration of compound (I) affected the viability of hepatocellular carcinoma cells (HepG2). The compound (I) showed cytotoxic effect on the HepG2 cancer cell line in dose dependant pattern and the IC 50 value was determined as 206.7µg/ml. With HepG2 below 206 µg/ml concentration no activity was observed but at 206 µg/ml there is a sharp increase in the inhibition and (90%) was observed. This is the first report of its kind to test the compound (I) from the essential oil of C.odorata for anticancer activity. Previous report showed that the Togos essential oil exhibited moderate cytotoxicity activity against human cell line HaCaT with an IC 50 value 700 µL.mL 
